We use our own cookies and third parties ones to offer our services and collect statistical data. If you continue browsing the internet you accept them. More information

Karolinska Institutet

Johan Bjureberg

Principal Investigator

Dr. Johan Bjureberg is Associate Professor and Research Group Leader at the Department of Clinical Neuroscience at the Karolinska Institutet in Stockholm, Sweden. His primary research focus revolves around the examination of maladaptive behaviors, encompassing self-injury, aggression, and suicide. The overarching objective of his research is to mitigate the adverse consequences of maladaptive behaviors. He achieves this by studying the mechanisms at play, devising efficacious interventions evaluated in randomized clinical trials, and facilitating the integration of these interventions into healthcare systems.

Oskar Flygare

Oskar Flygare is a postdoctoral researcher at Karolinska Institutet whose research focuses on understanding and treating suicidal thoughts and behaviors. He aims to develop effective treatments that can be delivered at scale, as well as studying suicidal thoughts and behaviors in epidemiological studies.

Marie Dahlin

Dr. Marie Dahlin is MD and Associate Professor at the Department of Clinical Neuroscience at the Karolinska Institutet. Dr. Dahlin’s research is dedicated to the fields of suicidology and student health.

Bo Runeson

Dr. Bo Runeson, is MD and Associate Professor at the Department of Clinical Neuroscience at the Karolinska Institutet. Dr. Runeson focus on suicide, violence, and mental ill-health. The methods have included both clinical patient samples and national population registers.

The PERMANENS project is supported by Instituto de Salud Carlos III (ISCIII) and by the European Union NextGenerationEU, Mecanismo para la Recuperación y la Resiliencia (AC22/00006; AC22/00045), the Swedish Innovation Agency (no. 2022-00549), the Research Council of Norway (project no. 342386) and the Health Research Board Ireland (ERAPERMED2022) under the frame of ERA PerMed.